Copenhagen, Denmark

Inga Vaarst

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Philip Morris Products S.a.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inga Vaarst. Retrieved from https://idiyas.com/inventor/inga-vaarst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inga Vaarst: Inventor in Virus-Like Particle Capture

Introduction

Inga Vaarst is an inventor associated with Copenhagen, Denmark, and Philip Morris Products S.A. Her work includes a patented method for capturing virus-like particles from plant-based mixtures using expanded-bed chromatography.

Latest Patents

Vaarst is associated with 1 patent: “Methods for Capturing Virus-Like Particles from Plants Using Expanded Bed Chromatography.” The invention describes contacting a mixture with an expanded bed of adsorbent so that its constituents interact with the adsorbent. The method may also include washing the adsorbent and eluting the particle of interest.

Career Highlights

Vaarst’s patent focuses on a process for capturing virus-like particles from mixtures. Expanded-bed adsorption can bring the mixture into contact with the adsorbent, followed by optional washing and elution steps.

Collaborations

The supplied information identifies Allan Lihme and Karen Oishi as Vaarst’s coworkers at Philip Morris Products S.A.

Conclusion

Inga Vaarst’s recorded invention addresses the capture of virus-like particles from plants through an expanded-bed chromatography method.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…